Clinical trial
Effect of the Inhibitors of the Way JAK-STAT on Regulatory B Cells in the Rheumatoid Arthritis
NCT03755297 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of the Inhibitors of the Way JAK-STAT on Regulatory B Cells in the Rheumatoid Arthritis
- Lead sponsor
- University Hospital, Montpellier
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 12, 2019
- Completion date
- November 12, 2022
- Enrollment
- 27 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis